.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Mfny (Marijuana Farms New York) is stocked at 325 licensed dispensaries across New York, with the deepest coverage in New York, Brooklyn, Queens, Buffalo, and Staten Island. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Mfny (Marijuana Farms New York) concentrated 45.29% of sales in Vapor Pens with 11.35% YoY growth and a 20.40% MoM lift, while Concentrates held 20.98% share with 42.76% YoY and 9.94% MoM gains; together these two inhalable formats represented 66.27% of mix, up from July on the back of Vapor Pens’ MoM surge. Edible slipped to 22.99% share with –1.96% YoY and –7.54% MoM, and Pre-Roll fell to 7.98% share with –25.93% YoY and –7.80% MoM; Tincture & Sublingual at 2.75% posted –13.15% YoY and –11.50% MoM, and Flower was negligible at 0.01% with –40.97% MoM. With Vapor Pens ranked 4th in New York for its category and the brand’s overall YoY sales at 7.81% alongside a –7.47% YoY average price shift to $34.19, the pattern implies a pivot toward higher-mix inhalables driving unit velocity while ingestibles and ancillary formats contract.
The shift toward Vapor Pens (+20.40% MoM) and Concentrates (+9.94% MoM) alongside category share declines in Edible (–7.54% MoM) and Pre-Roll (–7.80% MoM) implies Mfny (Marijuana Farms New York) is leaning into faster-cycling, potency-led baskets where a 4th-place rank in New York Vapor Pens can compound visibility. The –7.47% YoY average price movement, combined with double-digit YoY gains in Concentrates (+42.76%) and Vapor Pens (+11.35%), suggests price architecture is being used to broaden penetration without eroding premium cues in Concentrates (avg price $57.09). Net effect: the brand’s positioning is coalescing around inhalable leadership to lift share-of-wallet while de-emphasizing slower or declining formats, which, if sustained, can convert the August 2026 rank position and mix tilt into durable category leverage.
Competitive Landscape
Mfny (Marijuana Farms New York) sits at rank #4 in NY Vapor Pens in August 2026, improving 1 position year over year from #5, and holding steady versus three months ago at #4; this is its peak rank (#4) as of August 2026. In the competitive set, Fernway climbed from #3 to #1 with a 35.5% YoY sales increase while Jaunty slipped from #1 to #2 alongside a 24.3% YoY sales decline, and Ayrloom moved down from #2 to #3 with a 21.9% YoY decline; meanwhile, Jetty Extracts surged from #26 to #5 on 228.2% YoY growth. The pattern—Mfny (Marijuana Farms New York) advancing one rank while direct rivals above it either decline or face fast-rising entrants from below—implies a narrowing gap to the podium but rising pressure from below that will require share defense as leader dynamics rotate.
Notable Products
The steepest movement in August 2026 was a -15.1% MoM decline for Blueberry Razz x Zativa Live Resin Gummies 10-Pack (100mg), paired with Watermelon Lemonade x Candy Rain Live Resin Gummies 10-Pack (100mg) at -11.4% and the category’s lead Sour Green Apple x Sour Diesel Live Resin Gummies 10-Pack (100mg) at rank 1 with -13.4%, indicating concentrated weakness within Edibles. Across the top ten, seven SKUs are Edibles, yet the only MoM increase in the leaderboard came from Honey Banana Live Resin Cartridge (1g) at +9.1% while Hash Burger Live Resin Cartridge (1g) slipped -5.3% to rank 8, signaling a relative shift toward Vapor Pens performance. Despite Edibles occupying ranks 1, 2, 4, 5, 6, 7, and 9, their concurrent double‑digit pullbacks against a gaining flagship Vapor Pen suggest mix rebalancing toward inhalables where velocity may be steadier. The pattern implies Mfny (Marijuana Farms New York) is likely to lean into Vapor Pens to stabilize momentum while pruning underperforming Edible flavors.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
